Presentation Information
[PE-091]EFFECT OF GUSELKUMAB VERSUS USTEKINUMAB ON BIOMARKERS IN CHINESE PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: SUBGROUP ANALYSIS OF THE RANDOMIZED, DOUBLE-BLIND, PHASE 3 GALAXI 2 AND 3 STUDIES
Baili Chen2, *Xiang Gao3, Jie Zhang4, Qian Cao5, Yan Zhang6, Yan Chen7, Xuan Guo1, Scott Pina1, Jiajia Lu1, Wilbert van Duijnhoven1, Ting Zhao1, Minhu Chen2 (1. Johnson & Johnson, 2. The First Affiliated Hospital of Sun Yat-sen University, 3. The Sixth Affiliated Hospital of Sun Yat-sen University, 4. The Second Xiangya Hospital of Central South University, 5. Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 6. West China Hospital, Sichuan University, 7. The Second Affiliated Hospital of Zhejiang University School of Medicine)
Password required to view
Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.
The password will be emailed to those who have completed the registration.
Comment
To browse or post comments, you must log in.Log in